Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 4, Pages e61287
Publisher
Public Library of Science (PLoS)
Online
2013-04-09
DOI
10.1371/journal.pone.0061287
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nod2-Dependent Th2 Polarization of Antigen-Specific Immunity
- (2014) J. G. Magalhaes et al. JOURNAL OF IMMUNOLOGY
- MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action
- (2012) E. Caproni et al. JOURNAL OF IMMUNOLOGY
- Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
- (2012) Tobias Kamphuis et al. PLoS One
- Innate Immunity in the Respiratory Epithelium
- (2011) Dane Parker et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Defending the mucosa: adjuvant and carrier formulations for mucosal immunity
- (2011) Louise B Lawson et al. CURRENT OPINION IN IMMUNOLOGY
- Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands
- (2011) Muhammad Shafique et al. VACCINE
- Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells
- (2010) YanMei Liang et al. CLINICAL IMMUNOLOGY
- Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors
- (2010) Terese Petterson et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine
- (2010) Akira Ainai et al. JOURNAL OF MEDICAL VIROLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation
- (2010) Toon Stegmann et al. VACCINE
- The Synthetic Bacterial Lipopeptide Pam3CSK4 Modulates Respiratory Syncytial Virus Infection Independent of TLR Activation
- (2010) D. Tien Nguyen et al. PLoS Pathogens
- Transcriptional analysis of Toll-like receptors expression in M cells
- (2009) Siobhan B. Cashman et al. MOLECULAR IMMUNOLOGY
- TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity
- (2009) Teresa R. Johnson et al. VACCINE
- Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2
- (2008) M. R. Murawski et al. JOURNAL OF VIROLOGY
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
- (2008) Maria Florencia Delgado et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More